Presentation Information
[O7-05]EAGLアッセイを用いた細胞性免疫応答の中長期的なモニタリングはCOVID-19 mRNAワクチンがブレイクスルー感染後の症状に与える影響を明らかにする
*Taro Saito1, Arnaud Couzinet2, Toshihiro Suzuki2, Kei Miyakawa3, Tetsuya Nakatsura2 (1. Canon Medical Diagnostics Corp. R&D Div., 2. Division of Cancer Immunotherapy, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 3. Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama)